A Decision Support Tool for Pancreatic Cancer Screening -Aim 2

A Decision Support Tool for Pancreatic Cancer Screening -Aim 2

Pancreatic cancer has a rising incidence and poor survival. Early detection in high-risk individuals may substantially improve outcomes. Although guidelines recommend screening for individuals with hereditary cancer syndromes or certain genetic variants, pancreatic cancer screening remains uncertain due to limited evidence of mortality benefit, unclear screening strategies, potential harms, resource requirements, and low adherence. Shared decision-making between patients and providers is therefore essential, but no decision aid currently exists to support pancreatic cancer screening decisions. This record covers Aim 2, which will evaluate the acceptability, feasibility, and implementation of an electronic decision support tool designed to improve shared decision-making, value-concordant care, and screening adherence. The pilot study will also provide training in clinical trial methodology and support development toward an independent research career.

Inclusion Criteria:

• Adults who are eligible for pancreatic cancer screening according to current National Comprehensive Cancer Network guidelines.
• Not currently enrolled in a pancreatic cancer screening program.
• Referred to or previously seen at the UNC High Risk GI Cancer Clinic.
• English-speaking.
• Able and willing to provide informed consent.

Exclusion Criteria:

• Currently enrolled in a pancreatic cancer screening program.
• Does not meet pancreatic cancer screening eligibility criteria according to National Comprehensive Cancer Network guidelines.
• Unable or unwilling to provide informed consent.
• Non-English speaking.